Biomarkers in overactive bladder

International Urogynecology Journal

Volumn 24, Issue 7, 2013, Pages 1065-1072

  Bhide, Alka A ^a   Cartwright, Rufus ^a   Khullar, Vik ^a   Digesu, G Alessandro ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Brain derived growth factor; CRP; Cytokines; Nerve growth factor; Overactive bladder; Prostaglandins; Urinary biomarkers

Indexed keywords

BOTULINUM TOXIN A; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CD40 LIGAND; CELL MARKER; COMPLEMENT COMPONENT C1Q; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2; PROTEIN TYROSINE KINASE A; TOLTERODINE;

CLINICAL FEATURE; CYSTALGIA; CYTOKINE BLOOD LEVEL; CYTOKINE URINE LEVEL; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; GENE PRODUCT; GENETIC MARKER; HUMAN; INTERSTITIAL CYSTITIS; NERVE CELL PLASTICITY; NOCTURIA; NONHUMAN; OVERACTIVE BLADDER; PATHOPHYSIOLOGY; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; TREATMENT RESPONSE;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; NEURONAL PLASTICITY; URINARY BLADDER, OVERACTIVE;

EID: 84886869455     PISSN: 09373462     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-012-2027-1     Document Type: Review

References (38)

1. HaylenBT, deRidder D, FreemanRM, SwiftSE, BerghmansB,Lee J et al (2010) An International Urogynecological Association (IUGA)/ International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 21(1):5-26. doi:10.1007/s00192-009-0976-9
2. Cartwright R, Afshan I, Derpapas A, Vijaya G, Khullar V (2011) Novel biomarkers for overactive bladder. Nat Rev Urol Mar 8 (3):139-145
3. Chu FM, Dmochowski R (2006) Pathophysiology of overactive bladder. Am J Med 119 [3 Suppl 1]:3-8
4. Steers WD (2002) Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 4 [Suppl 4]:S7-S18.
5. Tanner R, Chambers P, Khadra MH, Gillespie JI (2000) The production of nerve growth factor by human bladder smooth muscle cells in vivo and in vitro. BJU Int 85(9):1115-1119 (Pubitemid 30348811)
6. Vizzard MA (2000) Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 161(1):273-284 (Pubitemid 30136549)
7. Moore KH, Simons A, Mukerjee C, Lynch W (2000) The relative incidence of detrusor instability and bacterial cystitis detected on the urodynamic-test day. BJU Int 85(7):786-792 (Pubitemid 30242778)
8. Hessdoerfer E, Jundt K, Peschers U (2011) Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder? Int Urogynecol J 22(2):229-232
9. Walsh CA, Siddins A, Parkin K, Mukerjee C, Moore KH (2011) Prevalence of "low-count" bacteriuria in female urinary incontinence versus continent female controls: a cross- sectional study. Int Urogynecol J 22(10):1267-1272
10. Oddiah D, Anand P, McMahon SB, Rattray M (1998) Rapid increase of NGF, BDNF and NT-3 mRNAs in inflamed bladder. Neuroreport 9(7):1455-1458 (Pubitemid 28264269)
11. Qiao LY, Vizzard MA (2002) Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways. J Comp Neurol 454(2):200-211 (Pubitemid 35265964)
12. Kim JC, Park EY, Seo SI, Park YH, Hwang TK (2006) Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 175(5):1773-1776
13. Liu HT, Chancellor MB, Kuo HC (2009) Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder. BJU Int 103(12):1668-1672
14. Liu HT, Lin H, Kuo HC (2011) Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourol Urodyn 30(8):1525-1529
15. Liu HT, Chancellor MB, Kuo HC (2009) Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 56(4):700-706
16. Kuo HC, Liu HT, Tyagi P, Chancellor MB (2010) Urinary nerve growth factor levels in urinary tract diseases with or without frequency urgency syndrome. LUTS 2:88-94
17. Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, Betelli C et al (2008) BDNF as a pain modulator. Prog Neurobiol 85(3):297-317
18. Michael GJ, Averill S, Nitkunan A, Rattray M, Bennett DL, Yan Q et al (1997) Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 17(21):8476-8490 (Pubitemid 27461069)
19. Pezet S, Malcangio M, McMahon SB (2002) BDNF: a neuromodulator in nociceptive pathways? Brain Res Brain Res Rev 40 (1-3):240-249
20. Pinto R, Frias B, Allen S, Dawbarn D, McMahon SB, Cruz F et al (2010) Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience 166(3):907-916
21. Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM et al (2010) Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol Sep 58 (3):360-365
22. Antunes-Lopes T, Pinto R, Carvalho-Barros S, Diniz P, Martins- Silva C et al (2012) Urinary levels of brain derived neurotrophic factor (BDNF) in women with overactive bladder (OAB) syndrome correlate with the severity of symptoms. Eur Urol Suppl 10(2):277-278
23. Bultitude MI, Hills NH, Shuttleworth KE (1976) Clinical and experimental studies on the action of prostaglandins and their synthesis inhibitors on detrusor muscle in vitro and in vivo. Br J Urol 48(7):631-637 (Pubitemid 8031581)
24. Ishizuka O, Mattiasson A, Andersson KE (1995) Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins. J Urol 153(6):2034-2038
25. Schussler B (1990) Comparison of the mode of action of prostaglandin E2 (PGE2) and sulprostone, a PGE2-derivative, on the lower urinary tract in healthy women. A urodynamic study. Urol Res 18:349-352 (Pubitemid 20344041)
26. Liu HT, Tyagi P, Chancellor MB, Kuo HC (2010) Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity. BJU Int 106(11):1681-1685
27. Tyagi P, Barclay D, Zamora R, Yoshimura N, Peters K, Vodovotz Y et al (2010) Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol 42 (3):629-635
28. Ghoniem G, Faruqui N, Elmissiry M, Mahdy A, Abdelwahab H, Oommen M et al (2011) Differential profile analysis of urinary cytokines in patients with overactive bladder. Int Urogynecol J 22 (8):953-961
29. Kushner I (1982) The phenomenon of the acute phase response. Ann N Y Acad Sci 389:39-48 (Pubitemid 12013176)
30. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111(12):1805-1812 (Pubitemid 38057722)
31. Hsiao SM, Lin HH, Kuo HC (2012) The role of serum C-reactive protein in women with lower urinary tract symptoms. Int Urogynecol J 23(7):935-940 doi:10.1007/s00192-012-1715-1
32. Chuang YC, Tyagi V, Liu RT, Chancellor MB, Tyagi P (2010) Urine and serum C-reactive protein levels as potential biomarkers of lower urinary tract symptoms. Urol Sci 21(3):132-136
33. Chung SD, Liu HT, Lin H, Kuo HC (2011) Elevation of serum creactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn 30(3):417-420
34. Kupelian V, McVary KT, Barry MJ, Link CL, Rosen RC, Aiyer LP et al (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey. Urology 73(5):950-957
35. Van der Hel OL, van der Luijt RB, Bueno de Mesquita HB, van Noord PA, Slothouber B, Roest M et al (2002) Quality and quantity of DNA isolated from frozen urine in population-based research. Anal Biochem 304(2):206-211 (Pubitemid 34522964)
36. Wennberg A-L, Altman D, Lundholm C, Klint A, Iliadou A, Peeker R et al (2011) Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins. Eur Urol 59(6):1032-1038
37. Rohr G, Kragstrup J, Gaist D, Christensen K (2004) Genetic and environmental influences on urinary incontinence: a Danish population-based twin study of middle-aged and elderly women. Acta Obstet Gynecol Scand 83(10):978-982 (Pubitemid 39331551)
38. Ferreira CE, Fonseca AM, Silva ID, Girão MJ, Sartori MG, Castro RA (2011) The relationship between the Trp 64 Arg polymorphism of the beta 3-adrenoceptor gene and idiopathic overactive bladder. Am J Obstet Gynecol 205(1):82.e10-4